Polar Capital Global Healthcare Trust Plc organizacji Cena/Sprzedaż
Jaka jest wartość Cena/Sprzedaż organizacji Polar Capital Global Healthcare Trust Plc?
Wartość Cena/Sprzedaż organizacji Polar Capital Global Healthcare Trust Plc to 5.41
Jaka jest definicja Cena/Sprzedaż?
Wskaźnik ceny do zysku (Price to sales ratio) to wskaźnik reprezentuje koszt firmy w porównaniu do kwoty jej sprzedaży.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena/Sprzedaż firm w Finance sektor na LSE w porównaniu do Polar Capital Global Healthcare Trust Plc
Czym się zajmuję organizacja Polar Capital Global Healthcare Trust Plc?
Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests in dividend paying growth stocks of large-cap companies having a market capitalization greater than US $5 billion. It employs fundamental analysis with a bottom up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI ACWI/Health Care Index. It was formerly known as Polar Capital Global Healthcare Growth and Income Trust plc. Polar Capital Global Healthcare Trust plc was formed on May 12, 2010 and is domiciled in the United Kingdom.
Firmy z cena/sprzedaż podobne do Polar Capital Global Healthcare Trust Plc
- Wartość Cena/Sprzedaż organizacji OP Investments to 5.40
- Wartość Cena/Sprzedaż organizacji SITE Centers Corp to 5.40
- Wartość Cena/Sprzedaż organizacji ICICI Securities to 5.40
- Wartość Cena/Sprzedaż organizacji Brookfield Select Opportunities Income Fund to 5.40
- Wartość Cena/Sprzedaż organizacji OptimizeRx to 5.40
- Wartość Cena/Sprzedaż organizacji Broadcom Inc to 5.41
- Wartość Cena/Sprzedaż organizacji Polar Capital Global Healthcare Trust Plc to 5.41
- Wartość Cena/Sprzedaż organizacji Neurocrine Biosciences to 5.41
- Wartość Cena/Sprzedaż organizacji West Bancorporation to 5.41
- Wartość Cena/Sprzedaż organizacji MEDIAN Technologies SA to 5.42
- Wartość Cena/Sprzedaż organizacji Gimv NV to 5.42
- Wartość Cena/Sprzedaż organizacji Hammerson Plc to 5.42
- Wartość Cena/Sprzedaż organizacji ELANTAS Beck India to 5.42